Search results for "Essential hypertension."

showing 10 items of 153 documents

Magnesium Responsiveness to Insulin and Insulin-Like Growth Factor I in Erythrocytes from Normotensive and Hypertensive Subjects

1998

Depletion of intracellular free magnesium (Mg(i)) is a characteristic feature of insulin resistance in essential hypertension, but it is not clear to what extent low Mg(i) levels contribute to insulin resistance, result from it, or both. As insulin-like growth factor I (IGF-I) may improve insulin resistance, we investigated whether this peptide could similarly improve Mg(i) responsiveness to insulin in hypertension, and whether this effect was related to any direct IGF-I effect on Mg(i). 31P-Nuclear magnetic resonance spectroscopy was used to measure Mg(i) in erythrocytes from 13 fasting normotensive and 10 essential hypertensive subjects before and 30, 60, and 120 min after incubation with…

AdultMalemedicine.medical_specialtyErythrocytesMagnetic Resonance SpectroscopyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryEssential hypertensionBiochemistryInsulin-like growth factorEndocrinologyInsulin resistanceReference ValuesInternal medicinemedicineHumansInsulinMagnesiumInsulin-Like Growth Factor IPancreatic hormoneDose-Response Relationship Drugbusiness.industryInsulinGrowth factorBiochemistry (medical)Middle Agedmedicine.diseaseRecombinant ProteinsPathophysiologyRed blood cellEndocrinologymedicine.anatomical_structureHypertensionFemalebusinessThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy

1993

The aim of this work was to study the insulin-like growth factor 1 (IGF1), a substance able to promote cell proliferation in vascular smooth muscle, in patients with mild-to-moderate hypertension and to analyse its relationship to sodium-lithium countertransport, a genetic marker of hypertension that is related to cardiovascular complications.We studied 32 hypertensive subjects, some with left ventricular hypertrophy, and 14 healthy subjects. Fasting plasma IGF1 was measured by means of a radioimmunoassay after octadecylsilica chromatography and Na(+)-Li+ countertransport was determined by the method of Canessa.Hypertensive patients had higher values of both IGF1 and Na(+)-Li+ countertransp…

AdultMalemedicine.medical_specialtyErythrocytesVascular smooth muscleLithium (medication)Heart diseasePhysiologymedicine.medical_treatmentEssential hypertensionLeft ventricular hypertrophyAntiportersMuscle hypertrophyInsulin-like growth factorReference ValuesInternal medicineInternal MedicineHumansMedicineInsulin-Like Growth Factor Ibusiness.industryGrowth factorMiddle Agedmedicine.diseaseEndocrinologyHypertensionFemaleHypertrophy Left VentricularCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension.

2006

The objective of the present study was to analyze the impact of metabolic syndrome (MS) and its individual components on oxidative stress (OX) and on the activity of antioxidant enzymes of patients with essential hypertension. One hundred and eighty-seven hypertensives, 127 (61.9%) of them having criteria for MS according to the International Diabetes Federation criteria and 30 healthy normotensive subjects were included. OX status was assessed by measuring glutathione oxidized/glutathione reduced and reactive oxygen species-induced byproducts of lipid peroxidation, malondialdehide, and DNA damage, 8-oxo-dG genomic and mitochondrial. Antioxidant enzymatic activity of Cu/Zn extracellular-sup…

AdultMalemedicine.medical_specialtyGPX1Antioxidantmedicine.medical_treatmentmedicine.disease_causeEssential hypertensionPeripheral blood mononuclear cellLipid peroxidationchemistry.chemical_compoundInternal medicineInternal MedicinemedicineHumansMetabolic Syndromebiologybusiness.industryGlutathioneMiddle Agedmedicine.diseaseOxidative StressEndocrinologychemistryCatalaseHypertensionbiology.proteinFemalebusinessOxidative stressJournal of human hypertension
researchProduct

Sympathetic Activity and Blood Pressure Pattern in Autosomal Dominant Polycystic Kidney Disease Hypertensives

1998

To study the potential role of sympathetic activity in the pathogenesis of arterial hypertension associated with autosomal dominant polycystic kidney disease (ADPKD) and to analyze its relationship with 24-hour blood pressure pattern, plasma catecholamines and 24-hour ambulatory blood pressure monitoring were evaluated in 30 ADPKD hypertensive patients (of which 17 without and 13 with renal failure) and in 50 essential hypertensives. The groups were matched for sex, body mass index, known duration of hypertension, and clinic blood pressure. Plasma catecholamines, determined in resting position, were higher in ADPKD patients without renal failure than in essential hypertensives. Nighttime di…

AdultMalemedicine.medical_specialtyHypertension RenalSympathetic Nervous SystemAmbulatory blood pressureAutosomal dominant polycystic kidney diseaseRenal functionHemodynamicsBlood Pressureurologic and male genital diseasesEssential hypertensionCatecholaminesInternal medicineReninmedicineHumansbusiness.industryBlood Pressure Monitoring AmbulatoryMiddle AgedPolycystic Kidney Autosomal Dominantmedicine.diseaseCircadian RhythmMean blood pressureBlood pressureEndocrinologyNephrologyCreatinineHypertensionCardiologyKidney Failure ChronicFemalebusinessKidney diseaseAmerican Journal of Nephrology
researchProduct

Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension.

2000

Abstract —The purpose of this research was to obtain further information about the role of polymorphonuclear leukocytes in essential hypertension. These cells could be involved in the pathogenesis of organ injury. Thirty subjects (14 men and 16 women) with essential hypertension were enrolled. In these subjects we determined, at baseline and after in vitro activation with 4-phorbol 12-myristate 13-acetate and N -formyl-methionyl-leucyl-phenylalanine, the polymorphonuclear leukocyte membrane fluidity, obtained by labeling the cells with 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene, cytosolic Ca 2+ concentration, obtained by marking the cells with Fura 2-AM, and integrin pattern (C…

AdultMalemedicine.medical_specialtyIntegrinsMembrane FluidityNeutrophilsIntegrinFluorescent Antibody TechniqueCD18CD11aEssential hypertensionCytosolInternal medicineInternal MedicinemedicineMembrane fluidityHumansAgedbiologyCell adhesion moleculehemic and immune systemsChemotaxisMiddle Agedmedicine.diseaseFlow CytometryEndocrinologyPhenotypeIntegrin alpha MHypertensionbiology.proteinCalciumFemaleHypertension (Dallas, Tex. : 1979)
researchProduct

The Association of Microalbuminuria With Aortic Stiffness Is Independent of C-Reactive Protein in Essential Hypertension

2009

BACKGROUND It has not been fully elucidated whether microalbuminuria (MAU) and high-sensitivity C-reactive protein (hsCRP) are associated with aortic distensibility independently of each other. Our study was aimed to evaluate the independent relationships of urinary albumin excretion rate (AER) and hsCRP with aortic stiffness in hypertensive patients. METHODS We enrolled 140 untreated nondiabetic essential hypertensives (mean age: 48 +/- 12 years). In all subjects, 24-hour AER and plasma levels of hsCRP were determined by immunoenzymatic assay. MAU was defined as an AER of 20-200 microg/min. Aortic stiffness was assessed by measurement of carotid-femoral pulse wave velocity (PWV). RESULTS C…

AdultMalemedicine.medical_specialtyMean arterial pressureEssential hypertensionMicroalbuminuria flogosi stiffness aorticaHeart RateInternal medicinemedicine.arteryInternal MedicineAlbuminuriaHumansMedicinecardiovascular diseasesPulse wave velocityAortaDemographyAortaProteinuriabiologybusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseC-Reactive ProteinEndocrinologyHypertensionbiology.proteinCardiologyFemaleAortic stiffnessMicroalbuminuriamedicine.symptombusinessAmerican Journal of Hypertension
researchProduct

Comparison of tumour necrosis factor and endothelin-1 between essential and renal hypertensive patients

1998

The present study was performed to compare circulating levels of tumour necrosis factor-alpha (TNFalpha) and plasma endothelin 1 (ET-1), of hypertensive patients with or without renal failure and with those of normotensive healthy subjects. The study population consisted of 21 healthy normotensive subjects and 22 hypertensive patients, 11 with essential hypertension, and 11 with hypertension and chronic renal failure (CRF). Plasma ET-1 levels, serum TNFalpha and creatinine, creatinine clearance, 24-h urinary albumin excretion (UAE) were assayed, and 24-h blood pressure monitoring was obtained in all subjects. Office blood pressure was similar between hypertensive patients with and without C…

AdultMalemedicine.medical_specialtyNecrosisRenal functionEssential hypertensionGastroenterologyExcretionchemistry.chemical_compoundInternal medicineInternal MedicinemedicineAlbuminuriaHumansCreatinineEndothelin-1Tumor Necrosis Factor-alphabusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseEndothelin 1Hypertension RenovascularBlood pressureEndocrinologychemistryCreatinineHypertensionKidney Failure ChronicFemalemedicine.symptombusinessKidney diseaseJournal of Human Hypertension
researchProduct

Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension

2002

The objective of the study was to assess the factors related to the occurrence of microalbuminuria during the follow-up of a young adult group with essential hypertension that had not been previously treated. Normo-albuminuric essential hypertensives, <50 years old, who had not been previously treated with antihypertensive drugs and who did not have diabetes mellitus were included. After the initial evaluation, patients were treated using only nonpharmacological measures (n=62), β-blockers (n=38), ACE inhibitors (n=64), calcium channel blockers (n=8), and several classes (n=15). Measurements were taken for office blood pressure, biochemical profile, and 24-hour urinary albumin excretion…

AdultMalemedicine.medical_specialtyNifedipineAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsEssential hypertensionEnalaprilLisinoprilRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaBisoprololHumansYoung adultAntihypertensive AgentsProportional Hazards ModelsProteinuriabusiness.industryFollow up studiesMiddle AgedCalcium Channel Blockersmedicine.diseaseTreatment OutcomeEndocrinologyBlood pressureAtenololHypertensionAlbuminuriaRegression AnalysisFemaleMicroalbuminuriamedicine.symptombusinessPreviously treatedHypertension
researchProduct

Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey

2019

Protein carbonylation is a marker of oxidative protein damage, that is likely involved in the pathogenesis of several diseases. The aim of this study was to evaluate the protein carbonyl (PC) groups in different clinical conditions. It included different groups of subjects: 81 trained subjects; 23 subjects with mild essential hypertension; 31 middle-aged subjects with metabolic syndrome (MS); 106 subjects with MS not selected for age (subdivided into two subgroups, with and without diabetes mellitus); 91 obese adults subdivided in two subgroups (BMI 30-35 Kg/m2 and BMI > 35 kg/m2); 48 subjects with obstructive sleep apnea syndrome (OSAS) subdivided in accordance with the apnea/hypopnea i…

AdultMalemedicine.medical_specialtyOxidative stress arterial hypertension metabolic syndrome juvenile myocardial infarction chronic kidney failurePhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyEssential hypertension030218 nuclear medicine & medical imagingProtein Carbonylation03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPhysiology (medical)Internal medicineDiabetes mellitusmedicineHumansDiseaseMyocardial infarctionDialysisbusiness.industryHematologymedicine.diseaseObstructive sleep apneaFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessOxidation-ReductionHypopneaBiomarkersKidney diseaseClinical Hemorheology and Microcirculation
researchProduct

Influence of risk factors on nitric oxide metabolites at the initial stage of juvenile acute myocardial infarction.

2009

Few data are accessible about the nitric oxide (NO) stable end-products (nitrite/NO2 − and nitrate/NO3 − :N O x) in acute coronary syndromes. An increase in inducible NO synthase (iNOS) was found during experimental myocardial infarction [13] and this increase persisted for 2 weeks. In experimental models of acute myocardial infarction (AMI) other authors [2] observed a NOx increase, a correlation between NOx level and iNOS activity and an inhibitory action carried out by S-methylisothiourea, that is an iNOS inhibitor [5]. The NOx level was also measured in a small group of patients with myocardial infarction in whom the peak of NOx elevation occurred 2 and 3 days after the onset of symptom…

AdultMalemedicine.medical_specialtyPhysiologyMyocardial InfarctionNitric Oxide Synthase Type IIEssential hypertensionNitric OxideNitric oxideCoronary artery diseasechemistry.chemical_compoundYoung AdultGriess testRisk FactorsPhysiology (medical)Internal medicinemedicineJuvenile myocardial infarction cardiovascular risk factors nitrite nitrateHumansMyocardial infarctionNitriteNOxbusiness.industryHematologyVenous bloodMiddle Agedmedicine.diseaseSurgerychemistryCase-Control StudiesCardiologyFemaleCardiology and Cardiovascular MedicinebusinessClinical hemorheology and microcirculation
researchProduct